华峰化学（002064）：业绩保持韧性，格局优化龙头具备弹性

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 10.64 CNY, based on a projected 19x PE for comparable companies in 2026 [3][7]. Core Insights - The company demonstrates resilient performance despite industry challenges, with a projected net profit of 1.944 billion CNY for 2025, reflecting a decrease from previous estimates [3]. - The report highlights an improving industry landscape for spandex, with the company positioned to benefit from both volume and price elasticity as supply constraints tighten and demand for elastic fabrics grows [11]. - The adipic acid sector is expected to recover from its current low profitability, with the company being a leading player in the market, benefiting from industry consolidation and demand recovery [11]. Financial Performance Summary - The company reported a revenue of 26.298 billion CNY in 2023, with a projected decline to 25.75 billion CNY in 2025, followed by growth in subsequent years [4]. - The net profit attributable to the parent company is forecasted to decrease to 1.944 billion CNY in 2025, with a recovery expected in 2026 and 2027 [4]. - The gross margin is expected to decline to 12.7% in 2025 but is projected to improve to 15.4% and 16.8% in 2026 and 2027, respectively [4].